World Wide Primates Inc.

World Wide Primates Inc., doing business as Primatebiologicals, is a Miami-based for-profit Subchapter S corporation that has been registered in SAM.gov since November 2002. The company specializes in the procurement, testing, quarantine, housing, and shipping of non-human primates to support biomedical research programs across multiple federal agencies. World Wide Primates Inc. has established itself as a critical supplier of specific pathogen-free primates sourced from diverse geographical origins, including India, China, Mauritius, and the Philippines, serving the federal government's research infrastructure needs in areas such as infectious diseases, vaccine development, medical countermeasures, and chemical threat studies.

World Wide Primates Inc. has demonstrated extensive federal contracting activity through numerous delivery orders, blanket purchase agreement calls, and purchase orders issued by military and civilian federal agencies. The company has supplied various primate species including African green monkeys (Cercopithecus aethiops), cynomolgus macaques from multiple origins (Mauritius, Philippines, China, and Asia), and marmosets to support biomedical research initiatives. Primary funding agencies awarding contracts to World Wide Primates Inc. include the National Institutes of Health Office of Logistics and Acquisition Operations, Defense Health Agency, Bureau of Medicine and Surgery (U.S. Department of the Navy), the Army Medical Command, Uniformed Services University of the Health Sciences, and Naval Supply Systems Command. The company's recent contract awards have ranged from $10,500 to $2.4 million in individual delivery order values, with the majority of contracts awarded as firm fixed-price arrangements on a competitive, non-set-aside basis. Contracts typically specify detailed requirements for primate species, age ranges, weight specifications, gender distribution, and specific pathogen-free certification status. World Wide Primates Inc. operates as the prime contractor on all identified awards, with no subcontractor involvement indicated in the available contracting records.

World Wide Primates Inc. currently holds three significant indefinite delivery contracts that serve as the primary vehicles for federal primate procurement. The largest IDV is a single-award indefinite delivery contract with the National Institutes of Health Office of Logistics and Acquisition Operations valued at approximately $29.5 million with a completion date of July 31, 2026, which covers comprehensive non-human primate acquisition, testing, transportation, and housing services. A second single-award indefinite delivery contract with the Department of the Navy Bureau of Medicine and Surgery is valued at approximately $5.96 million and extends through April 20, 2028, specifically for the procurement of Mauritius cynomolgus macaques. Most recently, the Defense Health Agency awarded World Wide Primates Inc. a multiple-award blanket purchase agreement valued at approximately $27.2 million with a completion date of November 16, 2028, which covers purchase, testing, quarantine, housing, and shipping of diverse non-human primate species including rhesus macaques from India and China, cynomolgus macaques from Mauritius and China, African green monkeys, and marmosets. The NIH and Bureau of Medicine and Surgery IDVs have generated substantial task orders over their respective periods of performance, with the NIH contract alone supporting dozens of delivery orders for varied primate species and quantities in support of the agency's biomedical research mission. Collectively, these three IDVs, totaling over $62 million in ceiling value, underscore World Wide Primates Inc.'s strategic importance as a primary federal supplier of research-grade non-human primates to the military and civilian biomedical research enterprise.